Bristol Myers (NYSE: BMY) EVP awarded market share units and performance shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Massacesi Cristian reported acquisition or exercise transactions in this Form 4 filing.
Bristol Myers Squibb executive Cristian Massacesi received new performance-based equity awards. On March 10, 2026, he was granted 26,122 Market Share Units and 39,184 Performance Shares, each tied to the company’s common stock. The Market Share Units cliff vest after three years, while payouts for both awards depend on Total Return and relative total shareholder return performance through around 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Massacesi Cristian
Role
EVP,Chief Med Offr,Head of Dev
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Market Share Units | 26,122 | $0.00 | -- |
| Grant/Award | Performance Shares | 39,184 | $0.00 | -- |
Holdings After Transaction:
Market Share Units — 26,122 shares (Direct);
Performance Shares — 39,184 shares (Direct)
Footnotes (1)
- Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
FAQ
What equity awards did BMY executive Cristian Massacesi receive on March 10, 2026?
Cristian Massacesi received two equity grants: 26,122 Market Share Units and 39,184 Performance Shares. Both are derivative awards linked to Bristol Myers Squibb common stock and are structured to vest and pay out based on future performance conditions set by the Board.
Are the new BMY equity awards to Cristian Massacesi open-market purchases or sales?
The Form 4 shows grant or award acquisitions, not open-market trades. Both the Market Share Units and Performance Shares were awarded at a stated price of $0.00 per unit as part of compensation, with no reported buying or selling in the open market.